Effective treatment of ascites remains one of the most important aspects in the management of patients with decompensated cirrhosis, especially in those who are not candidates for liver ...
J Gastroenterol Hepatol. 2009;24(9):1494-1503. With the application of molecular approaches, efforts towards measuring the bacterial load using DNA in SBP patients have recently been made ...
Not all patients with ascites respond to spironolactone, which is the standard treatment for this condition. However, the multinational HypoCAT study has found that satavaptan, a selective ...
If approved, Korjuny would become the only drug approved for the specific and cancer-directed treatment of malignant ascites, an abnormal accumulation of fluid in the peritoneal cavity that commonly ...